Downregulated miR-199 also increased levels of atherosclerosis-related biomarkers (Angiogenin, Galactin-3 and Neuropilin-1) in heart failure patients with peripheral artery disease [102]. The gene discussed is NRP1; the disease is peripheral arterial disease.